Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Securing wider EU commitment to the elimination of hepatitis C virus.
Wedemeyer H, Tergast TL, Lazarus JV, Razavi H, Bakoyannis K, Baptista-Leite R, Bartoli M, Bruggmann P, Buşoi CS, Buti M, Carballo M, Castera L, Colombo M, Coutinho RS, Dadon Y, Esmat G, Esteban R, Farran JC, Gillyon-Powell M, Goldberg D, Hutchinson S, Janssen HLA, Kalamitsis G, Kondili LA, Lambert JS, Marinho RT, Maticic M, Patricello A, Peck-Radosavljevic M, Pol S, Poljak M, Pop C, Sokol T, Sypsa V, Tözün N, Younossi Z, Aghemo A, Papatheodoridis GV, Hatzakis A. Wedemeyer H, et al. Among authors: dadon y. Liver Int. 2023 Feb;43(2):276-291. doi: 10.1111/liv.15446. Epub 2022 Dec 14. Liver Int. 2023. PMID: 36196744 Review.
Hepatitis C Virus Elimination Program among Prison Inmates, Israel.
Eisen L, Mor Z, Madar M, Rabinovitch R, Dadon Y, Sheffer R, Kaliner E, Goldstein L. Eisen L, et al. Among authors: dadon y. Emerg Infect Dis. 2023 Nov;29(11):2358-2361. doi: 10.3201/eid2911.230728. Emerg Infect Dis. 2023. PMID: 37877627 Free PMC article.
CONCERTO: A randomized, placebo-controlled trial of oral laquinimod in relapsing-remitting multiple sclerosis.
Comi G, Dadon Y, Sasson N, Steinerman JR, Knappertz V, Vollmer TL, Boyko A, Vermersch P, Ziemssen T, Montalban X, Lublin FD, Rocca MA, Volkinshtein R, Rubinchick S, Halevy N, Filippi M. Comi G, et al. Among authors: dadon y. Mult Scler. 2022 Apr;28(4):608-619. doi: 10.1177/13524585211032803. Epub 2021 Aug 11. Mult Scler. 2022. PMID: 34378456 Clinical Trial.
Laquinimod Safety Profile: Pooled Analyses from the ALLEGRO and BRAVO Trials.
Sørensen PS, Comi G, Vollmer TL, Montalban X, Kappos L, Dadon Y, Gorfine T, Margalit M, Sasson N, Rubinchick S, Knappertz V. Sørensen PS, et al. Among authors: dadon y. Int J MS Care. 2017 Jan-Feb;19(1):16-24. doi: 10.7224/1537-2073.2015-024. Int J MS Care. 2017. PMID: 28243182 Free PMC article.
Ocular adverse effects of systemic treatment with isotretinoin.
Neudorfer M, Goldshtein I, Shamai-Lubovitz O, Chodick G, Dadon Y, Shalev V. Neudorfer M, et al. Among authors: dadon y. Arch Dermatol. 2012 Jul;148(7):803-8. doi: 10.1001/archdermatol.2012.352. Arch Dermatol. 2012. PMID: 22508771